Efracea 40mg

Directions

Please refer to the medication’s patient information leaflet before starting any new medication.

• Take one capsule daily in the morning

• Swallow whole with a full glass of water

• Do not chew or crush the capsule

• Take on an empty stomach, at least 1 hour before or 2 hours after meals
  Storage instructions:

• Store below 25°C

• Keep in original packaging

• Keep out of reach of children

Ingredients

Active Ingredient:

• Doxycycline hyclate 40mg (modified-release)

Other Ingredients:

• Hypromellose

• Lactose monohydrate

• Magnesium stearate

• Talc

• Titanium dioxide

• Gelatin

Side Effects

Common side effects may include:

• Nausea

• Diarrhoea

• Headache

Serious (rare) side effects:

• Severe skin reactions

• Liver function changes

• Increased pressure in the skull

Stop the medicine and seek medical attention if serious side effects occur.

Warnings

Do not take Efracea 40mg MR Capsules if allergic to doxycycline or other tetracyclines. Not suitable for children under 12 or for use during pregnancy or breastfeeding unless advised by a doctor. Use with caution in patients with liver disease or a history of intracranial hypertension. Avoid prolonged sun exposure during treatment.

Efracea 40mg MR Capsules is a prescription medication used to treat moderate to severe rosacea in adults, specifically targeting inflammatory bumps and pimples. This modified-release capsule is designed for individuals requiring long-term anti-inflammatory therapy without the risk of antibiotic resistance.

How It Works

Efracea contains 40mg of modified-release doxycycline, a tetracycline-class compound with anti-inflammatory properties. At this sub-antibiotic dose, it reduces the activity of pro-inflammatory enzymes and suppresses the growth of certain skin bacteria involved in rosacea, while maintaining a lower risk of developing antibiotic resistance.

Why Choose Efracea 40mg MR Capsules

Efracea is uniquely formulated to deliver a consistent, controlled release of doxycycline, optimising its anti-inflammatory action while avoiding antibacterial resistance. Its once-daily dosing improves adherence and suits individuals who require long-term control of rosacea symptoms. Clinical studies have shown significant reduction in papules and pustules with minimal gastrointestinal upset compared to higher-dose tetracyclines.

Important Note

Efracea is not indicated for the treatment of bacterial infections or acne vulgaris. It should not be used in patients with known hypersensitivity to tetracyclines. Avoid sun exposure during treatment due to increased risk of photosensitivity. Consultation with a doctor is essential before starting therapy, especially for patients with liver impairment or those taking interacting medications.